Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0 | $7,500 | $686,000 | $284,000 |
| Research & development | $4.8M | $4.7M | $3.6M | $6.1M |
| Operating expenses | $11.0M | $11.0M | $8.1M | $9.7M |
| Operating income | −$11.0M | −$11.0M | −$7.5M | −$9.5M |
| EBITDAderived | −$10.8M | −$10.9M | −$7.3M | −$9.3M |
| Net income | −$11.0M | −$9.0M | −$11.3M | −$10.7M |
| Basic EPSper diluted share | -$2.25 | -$15.70 | -$54.98 | -$12.74 |
| Diluted EPSper diluted share | -$2.25 | -$15.70 | -$54.98 | -$12.74 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 18, 2026Form 4 | Salva Francisco D.President and CEO | BuySeries C Warrants · derivative | 4.06M | — | — | 4.06M |
| Mar 18, 2026Form 4 | Salva Francisco D.President and CEO | BuySeries B Warrants · derivative | 4.06M | — | — | 4.06M |
| Mar 18, 2026Form 4 | Salva Francisco D.President and CEO | BuySeries A Convertible Non-Redeemable Preferred Stock · derivative | 500 | — | — | 500 |